Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Cronos Group Inc(CRON)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for CRON
10/02/2026: CRON (3-star) is a REGULAR-BUY. BUY for 117 days. Simulated Profits (19.70%). Updated daily EoD!
Cronos Group Inc is a globally focused cannabis company known for its strong cash position and strategic partnership with Altria Group. Its primary business centers on the sale of recreational cannabis brands in Canada and the development of high-purity cannabinoid ingredients. The company's main growth opportunity lies in its scientific R&D, which targets unique, scalable product applications. However, investors face risks from intense price competition, regulatory hurdles, and a historically difficult path to consistent profitability. Cronos may best suit investors looking for long-term exposure to the cannabis sector who can tolerate volatility, while developments in U.S. federal policy and margin improvements remain key indicators to monitor.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | While the market potential is high, the sector's growth has been slower than once anticipated. |
| Momentum investor | Weak fit | The stock lacks sustained positive price momentum relative to broader market indices. |
| Value investor | Weak fit | Profitability remains elusive, making traditional value metrics difficult to apply. |
| Dividend investor | Weak fit | The company does not pay a dividend and focuses on cash preservation. |
| Low-risk investor | Weak fit | High industry volatility and regulatory uncertainty make this unsuitable for low-risk portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The cannabis sector is prone to speculative trading and sharp price swings. |
| Valuation risk | Medium / high | Market sentiment frequently disconnects from underlying business fundamentals. |
| Competition risk (Cannabis) | High | Oversupply and intense pricing wars among Canadian producers hurt margins. |
| Business quality | Medium | The company is transitioning to a more efficient, brand-focused business model. |
| Dividend income | Low / none | There is no income generation for shareholders. |
| Execution risk | Medium / high | Successfully scaling international operations remains a challenge. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 17.77% | Avg. Invested days 47 | Today’s Advisory Regular Buy |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 10/02/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.18B USD | Price to earnings Ratio 16.89 | 1Y Target Price 2.47 |
Price to earnings Ratio 16.89 | 1Y Target Price 2.47 | ||
Volume (30-day avg) 1.1M shares | Beta 1.28 | 52 Weeks Range 2.28 - 3.61 | Updated Date 10/01/2026 |
52 Weeks Range 2.28 - 3.61 | Updated Date 10/01/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.19 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Adult-Use Cannabis | Sale of dried flower, pre-rolls, and vaporizers in Canada. | This is the primary revenue engine currently driven by the Spinach brand. |
| Hemp-Derived CBD | Premium consumer products sold under the Lord Jones brand. | A growth segment focused on U.S. and wellness markets. |
| Geography: Canada | Core operations and distribution network. | The main market providing current cash flow and regulatory experience. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 16.89 | Forward PE 28.74 | Enterprise Value 464.00M | Price to Sales(TTM) 6.6 |
Enterprise Value 464.00M | Price to Sales(TTM) 6.6 | ||
Enterprise Value to Revenue 2.59 | Enterprise Value to EBITDA 51.47 | Shares Outstanding 368.41M | Shares Floating 186.99M |
Shares Outstanding 368.41M | Shares Floating 186.99M | ||
Percent Insiders 49.14 | Percent Institutions 15.47 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Cronos Group Inc
Exchange NASDAQ | Headquarters Stayner, ON, Canada | ||
IPO Launch date 2016-07-12 | President, CEO & Chairman Mr. Michael Ryan Gorenstein J.D. | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 610 | Website https://thecronosgroup.com |
Full time employees 610 | Website https://thecronosgroup.com | ||
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.